Colorectal cancer, commonly referred to as colon cancer, originates in the colon (large intestine) or rectum, typically as adenomatous polyps. It is unknown what causes cancer yet familial adenomatous polposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) are thought to increase risk of developing colon cancer. HNPCC is also referred to as Lynch Syndrome which can be divided into type I and type II. Individuals with this specific diagnosis are commonly diagnosed at a younger age than those without this condition. However, HNPCC as well as FAP can be screened in genetic testing. Additionally, increasing age, inflammatory intestinal conditions, nationality, low fiber and high fat diet, diabetes, smoking, alcohol, obesity, and a sedentary lifestyle can contribute to its onset. Treatments for colon cancer include surgery, chemotherapy, radiation therapy, and targeted drug therapy.
Hereditary Nonpolyposis Colorectal Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Hereditary Nonpolyposis Colorectal Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1301 products for the study of Hereditary Nonpolyposis Colorectal Cancer that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
Hereditary Nonpolyposis Colorectal Cancer is also known as Hereditary Non-polyposis Colon Cancer, Hereditary Nonpolyposis Colon Cancer, Hnpcc, Lynch Cancer Family Syndrome I, Lynch Syndrome.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.